Products

Ellescope MpRisk
Ellescope
Clinical Decision Support & Reference
Ellescope's MpRisk is a maternity risk-intelligence AI platform that provides antenatal risk assessment and prediction, identifying patients at risk of adverse maternal outcomes by synthesizing whole care records.

See all 1 product →

About Ellescope

Ellescope is a healthcare AI company focused on transforming maternity care through its data intelligence AI platform. The company’s primary offering, MpRisk®, is a clinical tool underpinned by biopsychosocial risk prediction AI models. These models are designed to dynamically evaluate maternal health risks at every stage of maternity and accurately predict the likelihood of common causes of maternal deaths, thereby enabling clear preventive care actions for clinicians. MpRisk® achieves this by aggregating and synthesizing clinical, psychosocial, and historical health data for expectant mothers to assess individualized severity of modifiable and non-modifiable risk factors impacting maternal outcomes.

Beyond risk assessment, Ellescope’s broader digital maternity platform automates risk-based care referrals and generates personalized care pathways, aiming to reduce the incidence of poor maternal outcomes. The company emphasizes closing the maternity intelligence gap by integrating complex data across care levels and enabling healthcare professionals to conduct rapid and analytical investigations using AI and scientific expertise. Ellescope’s solutions are designed to enhance and accelerate care management planning through maternal health screening and care pathway automation, with a mission to equip maternity services with tools that identify the care needs of mothers-to-be across all races and ethnicities.

Focus Areas

maternity data intelligence maternal health screening antenatal risk assessment psychosocial risk prediction care pathway automation reducing health inequalities in maternity care

Business Intelligence

TechnologyAI platform for maternity data intelligence, biopsychosocial risk prediction AI models, cloud-native (implied by digital platform)

What Physicians Need to Know

Specialization
Ellescope specializes in healthcare AI tools, specifically focusing on maternity data intelligence and risk prediction. Their platform, MpRisku00ae, is designed for antenatal risk assessment and prediction, identifying patients at risk of adverse maternal outcomes.
Key Differentiators
Ellescope differentiates itself by combining AI with scientific expertise to provide rapid and analytical investigations for antenatal and postnatal care. Their MpRisku00ae tool aggregates and synthesizes clinical, psychosocial, and historical health data to assess individualized maternal health risks. They are committed to equipping maternity services with tools that identify care needs across all races and ethnicities, aiming to close the maternity intelligence gap and address health inequalities.
Technology Stack
Ellescope utilizes AI, specifically biopsychosocial risk prediction AI models, to dynamically evaluate maternal health risks. Their platform performs data aggregation and processing, from early screening to point-of-care antenatal assessments. While specific programming languages or frameworks aren't detailed, their team includes applied AI scientists and engineering leaders responsible for the technical strategy and execution of their AI stack, ensuring security, robustness, and effectiveness.
Impact for Physicians
Ellescope's tools enable healthcare professionals to deliver rapid and analytical investigations, informing onward antenatal and postnatal care. MpRisku00ae provides a complete surveillance view of a patient's medical and psychosocial risks and their association with pregnancy, enhancing and accelerating care management planning through maternal health screening and care pathway automation. This helps clinicians make informed decisions, personalize care for expectant mothers, and increase staff efficiency by reducing the burden of data evaluation.
Physician Tip

For physicians, Ellescope's MpRisku00ae platform can significantly enhance early detection of poor maternal health and streamline care coordination. By providing a comprehensive view of a patient's biopsychosocial risks, it supports personalized care pathways and helps in making rapid, evidence-based decisions for antenatal and postnatal care. This can lead to improved patient outcomes and more efficient workflows, freeing up time for direct patient interaction. The platform's focus on integrated care delivery and addressing health inequalities also means it can help identify and support vulnerable patients more effectively.

While Ellescope's website focuses on its core maternity AI platform, other healthcare AI companies like Tellescope emphasize robust EHR integrations (e.g., athenahealth, Canvas Medical, DrChrono, Elation Health, Healthie, Medplum) and API capabilities for seamless data syncing and workflow automation. Ellescope's mission to close the maternity intelligence gap through complex data inclusivity across care levels suggests a need for strong integration capabilities to synthesize data from various sources. Secure and scalable infrastructure with HIPAA and SOC 2 compliance is crucial for such integrations in healthcare.

Products by Ellescope

1 product in the directory

Ellescope MpRisk
Ellescope
Clinical Decision Support & Reference
Ellescope's MpRisk is a maternity risk-intelligence AI platform that provides antenatal risk assessment and prediction, identifying patients at risk of adverse maternal outcomes by synthesizing whole care records.

What the Web Says

Ellescope is a company focused on closing the maternity intelligence gap through its AI-powered platform, MpRisk, which aims to personalize care for expectant mothers and increase staff efficiency. The platform assists in early detection of poor maternal health, risk-based care coordination, and addresses health inequalities by incorporating psychosocial analytical models. While there are positive sentiments from healthcare practitioners regarding the necessity and potential of Ellescope's solution, there is a lack of independent product or employer reviews on major platforms like G2, Glassdoor, Capterra, or Reddit.

Overall: Mixed

Strengths

  • Addresses the critical need for smart clinical systems in maternity care
  • Personalizes care for expectant mothers
  • Increases staff efficiency
  • Offers early detection of poor maternal health through MpRisk
  • Enhances care management planning through maternal health screening and care pathway automation
  • Utilizes clinically proven psychosocial analytical models to address health inequalities

Limitations

  • Lack of independent product reviews on G2, Capterra, and Glassdoor
  • No readily available employer reviews on major platforms
  • Limited public information on company culture or employee satisfaction

Based on reviews from: Ellescope website, DigitalHealth.London

Last updated: 2026-09-24

Videos

News, demos, and interviews about Ellescope.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ellescope →

View all on YouTube

Press & Coverage

Ellescope
Ellescope awarded Innovate UK Biomedical Catalyst Funding
Ellescope has been awarded 100% funding from Innovate UK as part of the Biomedical Catalyst to support a feasibility analysis on maternal health assessments in secondary care settings. This funding will help identify key outcome measures of pregnancy complications.
2024-06
Ellescope
SBRI funds 5 projects that help reduce health inequalities in maternity care
Ellescope's maternal health solution, piloted at First 4 Health Group, received an SBRI Healthcare phase-2 Funding Award of £500,000 to address health inequalities in maternity care within the NHS. This funding marks the official launch of their MedTech venture.
2024-02
DigitalHealth.London
Reconfiguring Maternity through Comprehensive Maternal Health Screening
Ellescope, an alumnus of the Accelerating FemTech programme, is using Innovate UK grants to advance its maternal health screening software. The company plans to conduct a clinical study in secondary care and develop a comprehensive regulatory and health economic strategy.
2024-10
Ellescope
Feasibility & proof of principle!
Ellescope's SBRI Phase-1 funded feasibility study demonstrated that proactive maternal health identification and stratification can effectively provide additional support to women across all maternity stages. The study, led by Sandra Nwokeoha, showed an overall improvement in 62.5% of patients' self-reported outcomes.
2023-07
Ellescope
A new landscape for digital maternity
Ellescope, founded in 2023, deploys a maternity risk-intelligence AI platform called MpRisku00ae for whole care record synthesis, inquiry, and shared care. MpRisku00ae is an antenatal risk assessment and prediction system that identifies individual patients at risk of adverse maternal outcomes.
2023-unknown
Universal Journal of Public Health
Advancing Maternal Outcomes with E-Health Interventions: A Scoping Review
This scoping review highlights that integrating e-health solutions into maternal healthcare can significantly reduce delays in emergency situations and improve maternal and perinatal outcomes. Digital interventions can reduce maternal and perinatal mortality through telemedicine and mHealth.
2026-02
MDPI
Smart Pregnancy: AI-Driven Approaches to Personalised Maternal and Foetal Healthu2014A Scoping Review
This scoping review examines the state-of-the-art applications of artificial intelligence in prenatal and perinatal medicine, critically analyzing barriers to widespread adoption and highlighting unresolved issues. The review aims to stimulate further investigation into translating computational innovations into equitable and personalized maternal-foetal healthcare.
2025-10

Frequently Asked Questions

Ellescope offers MpRisku00ae, a novel clinical tool utilizing biopsychosocial risk prediction AI models to dynamically evaluate maternal health risks at every stage of maternity. It predicts common causes of maternal deaths, enabling preventive care actions and generating automated risk-based care referrals and personalized care pathways to reduce poor maternal outcomes.
While Ellescope's specific compliance certifications aren't detailed, healthcare AI compliance generally requires satisfying HIPAA's technical safeguard requirements and FDA's clinical software classification standards. Organizations deploying AI must establish lawful authority for data use, ensure clear data governance, and have contracts defining data rights and vendor responsibilities.
Specific pricing for Ellescope is not publicly available. However, AI implementation costs in healthcare vary widely, with small-scale projects like patient support chatbots ranging from $10,000 to $50,000, and more complex diagnostic AI systems costing $50,000 to $300,000 or more. Ongoing costs include staff training, system upgrades, maintenance, and compliance monitoring.
The details of Ellescope's customer support are not specified. However, in general, AI customer support in healthcare can include 24/7 assistance, chatbots for instant answers, and personalized communication, aiming to improve patient experience and reduce administrative burden.
Ellescope was founded in 2023 via the Year Here social innovation program and has received Innovate UK start-up funding. They also work with Integrated Care Boards, Primary Care Networks, midwifery clinics, and other healthcare providers to configure integrated perinatal care pathways.
Ellescope was founded in 2023 and has received Innovate UK start-up funding in 2023 and 2024, indicating early-stage growth and recognition. They are also part of the 2026 Business Accelerator program with Praxis Portfolio Ventures.
Ellescope's mission includes equipping maternity services with tools that identify the care needs of mothers-to-be across all races and ethnicities, and their psychosocial analytical models are embedded to address health inequalities.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.